Utility of warning signs in guiding admission and predicting severe disease in adult dengue

Yee-Sin Leo, Victor C Gan, Ee-Ling Ng, Ying Hao, Lee-Ching Ng, Kwoon-Yong Pok, Frederico Dimatatac, Chi-Jong Go, David C Lye, Yee-Sin Leo, Victor C Gan, Ee-Ling Ng, Ying Hao, Lee-Ching Ng, Kwoon-Yong Pok, Frederico Dimatatac, Chi-Jong Go, David C Lye

Abstract

Background: The recommendation from the 2009 World Health Organization guidelines for managing dengue suggests that patients with any warning sign can be hospitalized for observation and management. We evaluated the utility of using warning signs to guide hospital admission and predict disease progression in adults.

Methods: We conducted a prospective cohort study from January 2010 to September 2012. Daily demographic, clinical and laboratory data were collected from adult dengue patients. Warning signs were recorded. The proportion of admitted patients using current admission criteria and warning signs was compared. The sensitivity, specificity, positive and negative predictive values of warning signs in predicting disease progression were also evaluated.

Results: Four hundred and ninety-nine patients with confirmed dengue were analyzed. Using warning signs instead of the current admission criteria will lead to a 44% and 31% increase in admission for DHF II-IV and SD cases respectively. The proportion of non-severe dengue cases which were admitted also increased by 32% for non DHF II-IV and 33% for non-SD cases. Absence of any warning signs had a NPV of 91%, 100% and 100% for DHF I-IV, DHF II-IV and SD. Of those who progressed to severe illness, 16.3% had warning signs on the same day while 51.3% had warning signs the day before developing severe illness, respectively.

Conclusions: Our findings demonstrated that patients without any warning signs can be managed safely with ambulatory care to reduce hospital resource burden. No single warning sign can independently predict disease progression. The window from onset of warning sign to severe illness in most cases was within one day.

Figures

Figure 1
Figure 1
Duration from onset of warning signs to DHF in outpatients (N = 49).

References

    1. Bhatt S, Gething PW, Brady OJ, Messina JP, Farlow AW, Moyes CL, Drake JM, Brownstein JS, Hoen AG, Sankoh O, The global distribution and burden of dengue. Nature. 2013. doi:10.1038/nature12060.
    1. World Health Organization. Dengue: Guidelines for diagnosis, treatment, prevention and control. Geneva: World Health Organization; 2009.
    1. World Health Organization. Dengue: Guidelines for diagnosis, treatment, prevention and control. Geneva: World Health Organization; 1997.
    1. Srikiatkhachorn A, Gibbons RV, Green S, Libraty DH, Thomas SJ, Endy TP, Vaughn DW, Nisalak A, Ennis FA, Rothman AL, Nimmannitaya S, Kalayanarooj S. Dengue haemorrhagic fever: the sensitivity and specificity of the WHO definition in identifying severe dengue cases in Thailand, 1994–2005. Clin Infect Dis. 2010;13:1135–1143.
    1. Ooi EE, Hart TJ, Tan HC, Chan SH. Dengue sero-epidemiology in Singapore. Lancet. 2001;13:685–686.
    1. Ooi EE, Goh KY, Gubler DJ. Dengue prevention and 35 years of vector control in Singapore. Emerg Infect Dis. 2006;13(6):887–893.
    1. Thein TL, Gan VC, Lye DC, Yung CF, Leo YS. Utilities and limitations of the world health organization 2009 warning signs for adult dengue severity. PLoS Negl Trop Dis. 2013;13:e2023.
    1. Lee LK, Earnest A, Carrasco LR, Thein TL, Gan VC, Lee VJ, Lye DC, Leo YS. Safety and cost savings of reducing adult dengue hospitalization in tertiary care hospital in Singapore. Trans R Soc Trop Med Hyg. 2013;13:37–42.
    1. Lee VJ, Lye DCB, Sun Y, Fernandez G, Ong A, Leo YS. Predictive value of simple clinical and laboratory variables for dengue hemorrhagic fever in adults. J Clin Virol. 2008;13(1):34–39.
    1. Lee VJ, Lye DC, Sun Y, Leo YS. Decision tree algorithm in deciding hospitalization for adult patients with dengue haemorrhagic fever in Singapore. Trop Med Int Health. 2009;13(9):1154–1159.
    1. Lai YLCY, Tan HC, Yap HF, Yap G, Ooi EE, Ng LC. Cost-effective real-time reverse transcriptase PCR (RT-PCR) to screen for dengue virus followed by rapid single-tube multiplex RT-PCR for serotyping of the virus. J Clin Microbiol. 2007;13(3):935–941.
    1. Gan VC, Lye DC, Thein TL, Dimatatac F, Tan AS, Leo YS. Implications of discordance in world health organization 1997 and 2009 dengue classifications in adult dengue. PLoS One. 2012;13(4):e60946.
    1. Marques N, Gan VC, Leo YS. Dengue myocarditis in Singapore: two case reports. Infection. 2013;13(3):709–714.
    1. Barniol J, Gaczkowski R, Barbato EV, da Cunha RV, Salgado D, Martinez E, Segarra CS, Sandoval EBP, Mishra A, Laksono IS, Lum LCS, Martinez JG, Nunez A, Balsameda A, Allende I, Ramirez G, Dimaano E, Thomacheck K, Akbar NA, Ooi EE, Villegas E, Hien TT, Farrar J, Horstick O, Kroeger A, Jaenisch T. Usefulness and applicability of the revised dengue case classification by disease: multi-centre study in 18 countries. BMC Infect Dis. 2011;13:106.
    1. Kalayanarooj S. Dengue classification: current WHO vs. the newly suggested classification for better clinical application? J Med Assoc Thai. 2011;13:74–84.
    1. Tsai CY, Lee IK, Lee CH, Yang KD, Liu JW. Comparisons of dengue illness classified based on the 1997 and 2009 world health organization dengue classification schemes. J Microbiol Immunol Infect. 2012. doi:10.1016/j.jmii.2012.1007.1005.
    1. Narvaez F, Gutierrez G, Perez MA, Elizondo D, Nunez A, Balmaseda A, Harris E. Evaluation of the traditional and revised WHO classifications of dengue disease severity. PLoS Negl Trop Dis. 2011;13:e1397.
    1. Prasad D, Kumar C, Jain A, Kumar R. Accuracy and applicability of the revised WHO classification (2009) of dengue in children seen at a tertiary healthcare facility in northern India. Infection. 2013. In Press.
    1. Vaughn DW, Green S, Kalayanarooj S, Innis BL, Nimmannitya S, Suntayakorn S, Endy TP, Raengsakulrach B, Rothman AL, Ennis FA. et al.Dengue viremia titer, antibody response pattern, and virus serotype correlate with disease severity. J Infect Dis. 2000;13(1):2–9.
    1. Balmaseda A, Hammond SN, Pérez L, Tellez Y, Saborío SI, Mercado JC, Cuadra R, Rocha J, Pérez MA, Silva S. et al.Serotype-differences in clinical manifestations of dengue. Am J Trop Med Hyg. 2006;13(3):449–456.
    1. Ministry of Health, Singapore. Weekly Infectious Disease Bulletin, Week 52, 2010. .
    1. Ministry of Health, Singapore. Weekly Infectious Disease Bulletin, Week 52, 2011. .
    1. Ministry of Health, Singapore. Weekly Infectious Disease Bulletin, Week 52, 2012. .
    1. College of Family Physician, Singapore. Primary care for management of dengue/dengue haemorrhagic fever during an outbreak. .
    1. Alexander N, Balmaseda A, Coelho IC, Dimaano E, Hien TT, Hung NT, Jänisch T, Kroeger A, Lum LC, Martinez E. et al.Multicentre prospective study on dengue classification in four South-east Asian and three Latin American countries. Trop Med Int Health. 2011;13(8):936–948.
    1. Jayaratne SD, Atukorale V, Gomes L, Chang T, Wijesinghe T, Fernando S, Ogg GS, Malavige GN. Evaluation of the WHO revised criteria for classification of clinical disease severity in acute adult dengue infection. BMC Res Notes. 2012;13:645.

Source: PubMed

Patrocinadores e Colaboradores

Condições médicas

Intervenções de drogas

3
Se inscrever